Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
[Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).
The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.
Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients.
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Primary alloproliferative TH1 response induced by immature plasmacytoid dendritic cells in collaboration with myeloid DCs.
Immunotherapy and therapeutic vaccines in HIV infection.
Multiparametric assay to screen and dissect the mode of action of anti-human immunodeficiency virus envelope drugs.
Inhibition of HIV-1 replication by RNA targeted against the LTR region.